AI Co., Biotech Prep IPOs Worth $602M As Novelis Delays

By Jade Martinez-Pogue · June 5, 2024, 6:16 PM EDT

Healthcare data artificial intelligence platform Tempus AI and Australian biotech Telix Pharmaceuticals on Wednesday unveiled plans for initial public offerings that will aim to raise a combined total of approximately $602...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login